ARS Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $-58.8M | $10.5M |
| FY2020 | — | $-14.1M | $386.6M |
| FY2021 | — | $-31.3M | $60.1M |
| FY2022 | — | $272.9M | $210.5M |
| FY2023 | — | $230.8M | $71.0M |
| FY2024 | $0 | $256.8M | $50.8M |
| FY2025 | $96.4M | $114.3M | $41.3M |